module3.1-section2-25

Contraception and HIV treatment

1. Finocchario-Kessler S, et al. AIDS Behav 2010;14:1106–14



What is effective contraception?

module3.1-section2-26

1. Pazol K, et al. Public Health Rep 2010;125:208–17
2. Heikinheimo O, et al. Hum Reprod Update 2009;15:165–76
3. Fakoya A, et al. HIV Med 2008;9;681–720



ARVs and oral contraceptives: Drug interactions

module3.1-section2-27

*EE = Ethinylestradiol; ‡ Co-administration with other hormonal/oral contraceptives containing progestogens other than norgestimate has not been studied, and therefore should be avoided. An alternate reliable method of contraception is recommended; ¥ Coadministration of FPV/r with oral contraceptives may increase the risk of hepatic transaminase elevations, alternative contraception methods are recommended; † For FPV/r and NFV alternative or additional contraceptive measures are recommended when administered with either EE- or norethindrone-containing hormonal contraceptives. SmPCs. Available at http://www.ema.europa.eu Accessed March 2011



European oral contraceptives ≥30 µg EE

30 µg EE

  • Femodene
  • Loestrin
  • Marvelon
  • Ovranette
  • Triadene

>30 µg EE

  • Brevinor
  • Cilest
  • Dianette
  • Norimin
  • Norinyl-1
  • Ovysmen
  • Synphase
  • Trinovum

SmPCs. Available at: http://www.medicines.org.uk/emc/. Accessed March 2011.